CORC

在结果中检索

CORC

浏览/检索结果: 共335条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Microstructure and stress-rupture property of DD32 nickel-based single crystal superalloy fabricated by additive manufacturing 会议论文
作者:  Ci, Shiwei;  Liang, Jingjing;  Li, Jinguo;  Wang, Haiwei;  Zhou, Yizhou
收藏  |  浏览/下载：9/0  |  提交时间：2020/12/18
Monocular adaptive inverse depth filtering algorithm based on Gaussian model 会议论文
Hefei, China, August 22-24, 2020
作者:  Xu, Chenglong;  Wu CD(吴成东);  Qu DK(曲道奎);  Sun HB(孙海波);  Song JL(宋吉来)
收藏  |  浏览/下载：22/0  |  提交时间：2020/10/10
A Multi-Object Grasping Detection Based on the Improvement of YOLOv3 Algorithm 会议论文
Hefei, China, August 22-24, 2020
作者:  Du, Kun;  Song JL(宋吉来);  Wang, Xiaofeng;  Li, Xiang;  Lin, Jie
收藏  |  浏览/下载：24/0  |  提交时间：2020/10/10
Synergistic effect for promoted benzene oxidation over monolithic CoMnAlO catalysts derived from in situ supported LDH film 会议论文
Tsukuba, JAPAN, DEC 05-06, 2017
作者:  Li, Shuangde;  Mo, Shengpeng;  Wang, Dongdong;  Wu, Xiaofeng;  Chen, Yunfa
收藏  |  浏览/下载：66/0  |  提交时间：2019/06/21
Risk Factors Related to the Development of Post Stroke Cognitive Impairment in Shanghai Stroke Population 会议论文
作者:  Dong Yi
收藏  |  浏览/下载：55/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace